HIVE BIO is pioneering a transformative approach to mental health through its global network of next-generation mental health centers. These centers leverage the potential of psychedelic-assisted therapy, targeting comprehensive healing for mental, emotional, and physical health challenges. Established in 2020 and headquartered in Malta, HIVE BIO marks a significant footprint across the Health Care, Health and Wellness, and Travel and Tourism industries.
The startup's innovative approach aims to expand access to integrated therapies that promise life-changing impacts on a global scale. Its focus on combining traditional therapeutic methods with psychedelics presents a cutting-edge solution to improve patient outcomes.
In its quest for growth and development, HIVE BIO secured a $1.60M Seed Round investment on 01 July 2021. This crucial backing came from The Conscious Fund, a prominent player in the psychedelic medicine investment ecosystem. The funding underscores the strategic, visionary potential investors see in HIVE BIO's mission and operational model.